Department of Pathology, University of Miami Miller School of Medicine, Miami, FL 33136.
Department of Obstetrics and Gynecology, New York-Presbyterian Hospital / Weill Cornell, New York, NY 10021.
Hum Pathol. 2018 Apr;74:122-128. doi: 10.1016/j.humpath.2018.01.007. Epub 2018 Jan 7.
Rhabdomyosarcoma (RMS) is an aggressive mesenchymal tumor most commonly diagnosed in the pediatric population, and when occurring in adults, tends to develop in the deep soft tissue of the limbs. Primary uterine RMS comprises an even more restricted subset, with little known or reported when compared to most other gynecologic sarcomas. Our goal with this study was to retrospectively evaluate cases from two academic institutions and describe the main histopathologic findings of this rare gynecologic malignancy. A total of 8 cases were identified, consisting of 4 pleomorphic rhabdomyosarcomas (PRMS), 2 alveolar rhabdomyosarcomas (ARMS), and 2 embryonal rhabdomyosarcomas (ERMS). They occurred in patients ranging from 22 to 70 years old, and the most common presenting symptom was vaginal bleeding. Most patients presented with advanced stage at diagnosis, including metastatic disease to lymph nodes and to distant sites. The masses were mostly (6/8) centered in the myometrium, while two cases arose in the cervix (2/8). Histologic characteristics of the tumors were dependent on the RMS subtype, although all cases demonstrated a similar immunohistochemical profile regardless of their subclassification. RMS of the uterus has a very poor prognosis, and data regarding treatment of this rare malignancy is limited, and usually extrapolated from non-uterine sites.
横纹肌肉瘤(RMS)是一种侵袭性间叶性肿瘤,最常见于儿科人群,而在成人中,往往发生在四肢深部软组织中。原发性子宫 RMS 构成了一个更为局限的亚组,与大多数其他妇科肉瘤相比,人们对其了解甚少或报道较少。我们进行这项研究的目的是回顾性评估来自两个学术机构的病例,并描述这种罕见妇科恶性肿瘤的主要组织病理学特征。共确定了 8 例病例,包括 4 例多形性横纹肌肉瘤(PRMS)、2 例腺泡状横纹肌肉瘤(ARMS)和 2 例胚胎性横纹肌肉瘤(ERMS)。它们发生在年龄为 22 至 70 岁的患者中,最常见的首发症状是阴道出血。大多数患者在诊断时已处于晚期,包括淋巴结和远处转移的疾病。肿块主要(6/8)位于子宫肌层,而 2 例发生在宫颈(2/8)。肿瘤的组织学特征取决于 RMS 亚型,尽管所有病例无论其分类如何,都表现出相似的免疫组织化学特征。子宫 RMS 的预后非常差,关于这种罕见恶性肿瘤的治疗数据有限,通常是从非子宫部位推断出来的。